Infant hearing screening: effects of timeline

Otolaryngology outcomes of infants with conductive hearing loss identified through universal newborn hearing screening

OBJECTIVE

Infants and children diagnosed with a conductive hearing loss (CHL) are often referred for otolaryngology assessment. Although this is also a regular occurrence for infants diagnosed with a CHL through Universal Newborn Hearing Screening (UNHS), less is known about these infants and their outcomes. Using a cohort of infants diagnosed with CHL through UNHS and referred to otolaryngology, this study aimed to investigate the relationship between specific demographic or clinical characteristics and 1) triage category 2) middle ear diagnosis and intervention and, 3) service-related factors at otolaryngology.

METHODS

Retrospective analysis through clinical chart review was performed on all infants born between January 2014 and December 2017 who referred on UNHS, diagnosed with a CHL and referred to the Queensland Children's Hospital. Descriptive analysis and Chi squared analysis was conducted on data from 95 records.

RESULTS

Analysis between all infants referred from UNHS and those who referred, diagnosed with CHL and then referred to otolaryngology suggest that bilateral referrals/medical exclusion, preterm and infants with ≥1 risk factors are more readily associated with referral to otolaryngology for CHL. Nearly all (92.86 %) infants who were referred to otolaryngology had a primary diagnosis of OM and most infants (89.66 %) received grommets as an intervention. The average age of first appointment at otolaryngology was 427 days, the average age of intervention was 579 days and the average occasions of service at otolaryngology was 6.72.

CONCLUSION

This paper provides a snapshot into the journey and outcomes of infants referred from UNHS, diagnosed with CHL, and referred to otolaryngology. Further investigation in both general and UNHS populations is needed to better understand and apply these findings.

Brainstem auditory evoked responses in foals: reference values, effect of age, rate of acoustic stimulation, and neurologic deficits

Background

Age and rate of acoustic stimulation affect peak latencies in brainstem auditory evoked responses (BAER) in humans. Those effects are unknown in foals.

Hypothesis/Objectives

Our goals were to (1) establish reference values for BAER in foals by using 3 different stimulation protocols, (2) evaluate the effects of age and stimulation frequencies on BAER tracing in foals up to 6 months old, and (3) compare the data with BAER obtained from foals with central nervous system (CNS) disorders.

Animals

Thirty‐nine neurologically normal foals and 16 foals with neurologic diseases.

Methods

Prospective observational clinical study. BAER recorded by using 3 protocols of stimulation (11.33 repetitions per second [Hz]/70 decibel normal hearing level [dBNHL]; 11.33 Hz/90 dBNHL; 90 Hz/70 dBNHL).

Results

No effect of age was observed in normal foals (P > .005). No significant difference was observed for latencies and interpeak latencies (IPL) when comparing foals with neurologic diseases and normal foals (P > .05), but 78.6% of foals with neurologic diseases had an asymmetry in their tracing, reflecting a difference in conduction time between the left and right side of the brainstem. Increasing the stimulation rate did not improve detection of CNS disorders.

Conclusions and Clinical Importance

We propose BAER reference values for foals up to 6 months of age by using 3 protocols. Most foals with neurologic deficits had abnormal BAER tracing.

Development of a test to evaluate olfactory function in a pediatric population

OBJECTIVES/HYPOTHESIS

This study evaluated two versions of a test for olfactory function to determine suitability for use in a pediatric population.

STUDY DESIGN

Cross-sectional cohort study.

METHODS

In phase 1, 369 children (ages 3-17 years) and 277 adults (parents) were tested. Children began with identification and familiarity judgments to pictures representing target odors and distractors. Odors were administered via a six-item scratch and sniff test. Each answer sheet contained the correct odor source and three distractors. In phase 2, 50 children (ages 3-4 years) and 43 adults were given a revised version with eight odors judged more representative of the source and familiar to children.

RESULTS

Both completion time and identification accuracy in phase 1 improved with age. Accuracy of children 5 years old and above equaled adults for two of the three best odors. In phase 2, adults' accuracy significantly improved relative to phase 1 (92% vs. 68%), and exceeded that of 4 year olds for four of eight odors and 3 year olds for seven of eight odors.

CONCLUSIONS

Children as young as 3 years of age can perform olfactory testing, but take longer than do older children and adults (7.44 vs. 5.66 vs. 3.71 minutes). Identification accuracy also increases as a function of age. The current six-item National Institutes of Health Toolbox Odor Identification Test is a brief, easily conducted test for evaluating olfactory ability. Collection of normative data for children of all ages and adults is needed to determine the clinical utility of the test and its interpretations for pathological conditions.

Evaluating the prevalence of olfactory dysfunction in a pediatric population

Although smell loss has several potential etiologies (e.g., head trauma, allergic rhinitis, and enlarged adenoids) that are common among children, studies evaluating the prevalence of olfactory dysfunction in the pediatric population are rare. Several challenges confront the clinician or researcher hoping to evaluate odor identification ability in young children. Children are likely to be unfamiliar with many of the odor stimuli used in adult tests and have limited ability to read and identify labels to select from alternative choices, which is the typical adult response option. Consequently, specialized forms of olfactory tests must be developed for this population. Based on the format of the San Diego Odor Identification Test(1) and the delivery system of the Brief Smell Identification Test,(2) we are developing a short form odor identification test utilizing standardized odor stimuli in which participants match 6 odorants to pictures of the odor source. The pilot version of this test is being administered to children between the ages of 3-17 as part of the pre-surgical intake evaluation at the A.I. duPont Hospital for Children and as part of basic research studies at the Monell Center. The hospital study population is broad and includes children undergoing ear, nose, and throat surgery as well as controls subjects (children undergoing general surgery), with approximately 50 children per week eligible for evaluation. To improve correct interpretation of the results, stimulus familiarity is evaluated by having the child's parent/guardian also complete the test and answer a short questionnaire about the child's experience with the various odor stimuli. The challenges confronted in studying this clinical population as well as extrapolation to larger populations will be discussed.

Otoacoustic detection of risk of early hearing loss in ears with normal audiograms: a 3-year follow-up study

INTRODUCTION

Distortion product otoacoustic emissions (DPOAEs) are known to represent the contractile amplifier function of cochlear outer hair cells. It is known that low or absent DPOAEs are associated with hearing loss on audiograms. However, low DPOAEs can also be found associated with normal audiograms. It is unknown whether low DPOAEs in normal hearing ears are risk markers for subsequent early hearing loss when subjects are exposed to noise.

MATERIALS AND METHODS

A 3-year follow-up study was carried out on a population of pilots aged 20-40 years (n=521). Data collection consisted of tonal audiograms, DPOAEs measurements with a calculation of an index of abnormality (the IaDPOAE). Of the 521 pilots enrolled, 350 (67%) had follow-up data 3 years later. In pilots with normal audiograms (n=219, all frequencies=10dB HL), we observed the occurrence of hearing threshold shifts after 3 years depending on whether the IaDPOAE was initially high (group 1) or low (group 2). We used this index to test the hypothesis that reduced DPOAEs levels are potential ear vulnerability biomarkers in apparent normal hearing ears. After a 3-year follow-up, the initial IaDPOAE in normal hearing subjects was correlated with final noise-induced hearing threshold shifts at high frequencies (p<0.01). The occurrence of abnormal audiograms was significantly higher in group 1 compared to group 2 (p=0.003). In group 1, 13% of audiograms were found with at least one frequency 25dB HL compared to 3% of audiograms in group 2. In both groups, impairments occurred at high frequencies and hearing in the 4kHz frequency range was significantly more impaired in group 1 (p=0.035). Group 1 was associated with a relative risk of 2.29 (95% CI 1.26-4.16, p=0.005) of sustaining early hearing loss. There was no significant differences between groups for age and noise exposure.

DISCUSSION

In adults with a normal audiogram, ear vulnerability to noise could be elicited by the use of objective DPOAE measurements. A high IaDPOAE that corresponded to reduced DPOAE levels constitutes a risk for early hearing loss. This study emphasised the interest of DPOAE measurements in public health and occupational noise prevention policies. The IaDPOAE calculation may also be interesting for clinicians because no DPOAE index of abnormality is currently available.